The American Association of Immunologists (AAI) has named microbiology professor John Kearney, Ph.D., the 2016 AAI-BioLegend Herzenberg Award for his outstanding research contributions to the field of immunology in the area of B cell biology.
Kearney came to UAB in 1973 and has been a full professor in the UAB Department of Microbiology since 1983. He is an internationally recognized expert in monoclonal antibodies and their source: immune cells known as B cells that produce the antibodies necessary to fight off infections and other immune threats. His work has brought worldwide recognition to UAB. In addition to his primary faculty appointment in the microbiology department, Kearney holds several other appointments at UAB including senior scientist in the UAB Comprehensive Cancer Center and UAB Center for Disease Preparedness, as well as a professor in the Division of Developmental and Clinical Immunology.
Kearney will be recognized at the AAI annual meeting on May 12-17 in Seattle, Washington.
The AAI-BioLegend Herzenberg Award was established in 2014 by AAI, in partnership with BioLegend Inc., a provider of antibodies and reagents for biomedical research.
Read more
Kearney came to UAB in 1973 and has been a full professor in the UAB Department of Microbiology since 1983. He is an internationally recognized expert in monoclonal antibodies and their source: immune cells known as B cells that produce the antibodies necessary to fight off infections and other immune threats. His work has brought worldwide recognition to UAB. In addition to his primary faculty appointment in the microbiology department, Kearney holds several other appointments at UAB including senior scientist in the UAB Comprehensive Cancer Center and UAB Center for Disease Preparedness, as well as a professor in the Division of Developmental and Clinical Immunology.
Kearney will be recognized at the AAI annual meeting on May 12-17 in Seattle, Washington.
The AAI-BioLegend Herzenberg Award was established in 2014 by AAI, in partnership with BioLegend Inc., a provider of antibodies and reagents for biomedical research.
Read more